Get short, timely messages from EvaluatePharma.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @evaluatepharma.

Get updates via SMS by texting follow evaluatepharma to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

evaluatepharma

  1. Takeda continues ambitious emerging market push with acquisition in Brazil - @EPVantage investigates: ow.ly/bf1XI 6:13 AM May 30th via HootSuite
  2. Big pharma keeps cutting jobs, but the underlying trends are more complex - @epvantage investigates: ow.ly/b6mgl 9:06 AM May 23rd via HootSuite
  3. Lundbeck chief executive Ulf Wiinberg talks to @EPVantage about the company’s CNS-focused late stage pipeline: ow.ly/b5T14 4:35 AM May 23rd via HootSuite
  4. As largest creditor sues, Savient shares continue to fall; a further 46% week-on-week - Weekly Market Movers to May 18: ow.ly/b2JIT 9:35 AM May 21st via HootSuite
  5. Positive topline trial results for antidepressant Lu AA21004 gladdens Lundbeck and Takeda - EP Vantage investigates: ow.ly/b2JxT 6:33 AM May 21st via HootSuite
  6. AB Science stock up 22% as recruitment starts for pIII studies of masitinib in Gleevec-resistant GI stromal tumours: ow.ly/b2Iwh 6:29 AM May 21st via HootSuite
  7. Pfizer’s future blockbuster, rheumatoid arthritis pill tofacitinib, gets FDA backing - @EPVantage reports: ow.ly/aY5QK #pfizer #FDA 2:09 AM May 17th via HootSuite
  8. Arena Pharma soars +146% as FDA advisory panel votes to approve obesity drug, Lorqess - Weekly Market Movers to May 11: ow.ly/aT9P5 3:32 AM May 14th via HootSuite
  9. Vertex’s life after Incivek looking up after positive VX-809 data - @EPVantage reports: ow.ly/aNLIg #Vertex #pharma 9:32 AM May 9th via HootSuite
  10. Phase III trial success for macitentan sees Actelion market cap up $864m – Weekly Market Movers to May 4: ow.ly/aM6hC 9:05 AM May 8th via HootSuite
  11. Protalix, Pfizer face fight for share after finally winning Gaucher approval, @EPVantage reports: ow.ly/aHgH7 3:13 AM May 4th via HootSuite
  12. Warner Chilcott could attract suitors - revenues might be diminishing, but profitability is projected to rise: ow.ly/aGbG5 8:59 AM May 3rd via HootSuite
  13. Novelos stock +67% as cancer-targeted PET imaging agent shows positive initial results - Weekly Market Movers to Apr 27 ow.ly/aB8CB 2:59 AM Apr 30th via HootSuite
  14. AstraZeneca in need of new strategy as CEO David Brennan stands down - EP Vantage investigates: ow.ly/ayKre 8:08 AM Apr 27th via HootSuite
  15. EvaluatePharma 2018 outlook: Novartis to be number one for 2018 and Pfizer the sole US pharma company in top five - ow.ly/ax2ib 6:33 AM Apr 26th via HootSuite
  16. Endocyte shares up 95% after licensing rights of phase III vintafolide to Merck & Co – Weekly Market Movers to Apr 20: ow.ly/asqbF 8:18 AM Apr 23rd via HootSuite
  17. Human Genome Sciences shares up 100% as company rejects GlaxoSmithKline takeover offer – Weekly Market Movers to 20 Apr ow.ly/arZ77 3:45 AM Apr 23rd via HootSuite
  18. GlaxoSmithKilne offer needs to be sweeter to capture partner's heart - Human Genome Sciences reject opening offer: ow.ly/apEmI 8:33 AM Apr 20th via HootSuite
  19. PDUFA date for Uplyso finally draws nears - but has Protalix missed the chance to claim Gaucher's market share? :ow.ly/anyNA 1:44 AM Apr 19th via HootSuite
  20. In the absence of a treatment for Alzheimer's, state and private payers unwilling to pay for diagnostics: ow.ly/ajjEZ 8:40 AM Apr 16th via HootSuite
  • Name EvaluatePharma
  • Location London, Boston & Tokyo
  • Web http://www.evalua...
  • Bio Aspiring to be the premier source for pharma and biotech analysis, delivering exclusive commercial insight into industry performance.
29 Following 300 Followers 14 Listed
FierceMedicalDevices Eucomed WSJ Health Blog EPClinicalTrials Denise Peterson LESUSACanada BioNetwork EBD Group Adam Fein Pharma Twits Ben Hirschler Biotechnology partneringNEWS Ellen Licking Mike Auerbach FDAnews Pharma BRA MassBio Pharma Whistleblower BioPharmInsight MedTRACK EP Vantage Life Science Leader EP Vantage PharmTechGroup Pharm Exec Global Jeffrey Clark Pharm Exec Magazine BIO Intl Convention